Browse by category

GI Dynamics, the creator of the EndoBarrier device designed to target the underlying cause of type 2 diabetes, has announced it has...

Phenomix Sciences has launched its second of its gut-brain axis phenotyping test, MyPhenome Hungry Brain, new buccal swab test that...

Vogenx has announced positive results from its VGX 001-011 study, a phase 2 multi-centre, randomised, sequential crossover, single...

Eiger BioPharmaceuticals has revealed it will focus its development efforts on advancing avexitide in hyperinsulinemic hypoglycaemia...

The UK’s National Institute for Health and Care Excellence (NICE) has not recommended tirzepatide (Mounjaro, developed by Eli Lilly) in...

ReShape Lifesciences has submitted a Premarket Approval (PMA) supplement application to the FDA for the company’s next generation,...

Allurion has entered a pilot collaboration agreement with Medtronic, to expand access to Allurion’s AI-powered weight loss programme...

Novo Nordisk is taking multiple actions to protect US patients from the unlawful marketing and sales of non-FDA approved counterfeit and...

Innova Care Concepts has revealed that its Interlude 500 ultra-low bariatric care bed will now incorporate the VersaDrive, a unique...

Health Canada has approved Rhythm Pharmaceuticals’ IMCIVREE (setmelanotide solution for subcutaneous injection) for weight management in...